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Summary
Although CD95L is required for T cell receptor (TCR)-
induced cell death (TCR-ICD) in T helper 1 cells, the
molecular mechanisms mediating TCR-ICD in Th2
cells are unknown. We found that death receptors
were not involved in TCR-ICD of Th2 cells because
blocking their cognate ligands had no effect on apo-
ptosis of activated Th2 cells. Furthermore, we showed
that caspases were not actively involved in TCR-ICD of
Th2 cells. However, inhibition of granzyme B (GrB) ac-
tivity abolished TCR-ICD in Th2 cells but not Th1 cells.
Likewise, Th2 cells derived from GrB-deficient mice
were resistant to TCR-ICD, and GrB deficiency or inhi-
bition of GrB activity consequently enhanced the pro-
duction of Th2 cytokines. GrB-deficient mice exhibited
increased susceptibility to allergen-induced asthma.
Thus, GrB plays a critical role in the TCR-ICD of Th2
cells.
Introduction
Mature T cells are at rest until they recognize antigen
and can survive for several months in rodents and years
in humans (Sprent and Tough, 1994). Upon T cell recep-
tor (TCR) stimulation, T cells become activated and initi-
ate specific immune responses. These activation signals
are often robust: with an appropriate costimulus, contin-
uous TCR stimulation can cause cell numbers to in-
crease by a factor of 109 to 1011 in just 60 days (Levine
et al., 1997). Unchecked T cell expansion after TCR acti-
vation is detrimental. Thus, effective control mecha-
nisms have evolved alongside this extraordinary po-
tential for T cell expansion. Activated T cells require
substantial amounts of cytokines, especially interleu-
kin-2 (IL-2) and IL-7, for sustained survival. Once the ac-
tivation signals diminish, either by depletion of antigen
or by increased inhibitory signals, cytokine production
drops off, resulting in death or clonal contraction of T
cells by cytokine deprivation (Akbar and Salmon, 1997;
Janssen et al., 2000; Vella et al., 1998). In addition, pre-
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gagement of their TCR, helping to maintain peripheral
tolerance and cellular homeostasis (Lenardo, 1991;
Mercep et al., 1988; Shi et al., 1989).
The discovery of the T helper 1 (Th1) and Th2 dichot-
omy was a landmark in the understanding of the mech-
anisms regulating immune responses during infections,
autoimmunity, and tumorigenesis (Mosmann et al.,
1986; Murphy et al., 2000). It is well established that
the cytokine milieu plays a critical role in helper T cell dif-
ferentiation (Paul and Seder, 1994). Modulation of the
availability of key cytokines such as IL-4, interferon-g,
(IFN-g), IL-12, and IL-10 either by antibody neutralization
or through exogenous supplementation leads to distinct
patterns of helper T cell differentiation (Mosmann and
Sad, 1996; Zhang et al., 2003). CD4+ helper T cells differ-
entiate into two phenotypically distinct subpopulations:
Th1 cells, which are promoted by IL-12 and IFN-g in the
absence of IL-4, and Th2 cells, which are favored by IL-4
and IL-10 in the absence of IL-12 and IFN-g (Constant
and Bottomly, 1997; Mosmann et al., 1986; Paul and
Seder, 1994).
The granzyme family of serine proteases are pivotal
mediators of apoptosis utilized by cytotoxic T lympho-
cytes and natural killer cells against targets such as
virus-infected cells and tumor cells (Lieberman, 2003).
The most demonstrated function of granzymes is their
induction of target cell apoptosis after entry via a still-
uncharacterized perforin-assisted mechanism (Lieber-
man, 2003; Raja et al., 2003). Interestingly, granzymes
can also act upon the cells harboring them; it has been
found that CD16 ligation-induced apoptosis of NK cells
results from the release of granzyme B (GrB) from cyto-
plasmic granules (Ida et al., 2003). GrB has also been re-
ported in the cytosol of CD2-activated cytotoxic T cells
(Bidere et al., 2002). In addition, granzymes may be in-
volved in glucocorticoid-induced apoptosis in B leuke-
mia cells (Yamada et al., 2003). The presence of GrB in
CD4+ T cells was reported by several studies soon after
its discovery (Fruth et al., 1987) and was believed to be
associated with their cytotoxic activity. The function of
GrB in CD4+ helper T cells has been largely ignored,
however, and remains a mystery, even as much prog-
ress has been made in elucidating the function of gran-
zymes in NK cells and cytotoxic T cells.
Th1 and Th2 cells differ not only in their cytokine-
secretion profiles, but also in their tendencies to un-
dergo TCR-induced cell death (TCR-ICD) and in their ex-
pression of CD95L (Oberg et al., 1997; Ramsdell et al.,
1994). We have reported that CD95L and tumor necrosis
factor (TNF)-related apoptosis-inducing ligand (TRAIL)
are differentially expressed in Th1 and Th2 cells after
TCR activation; TRAIL is expressed mainly by Th2 cells,
and CD95L is detected preferentially in Th1 cells (Zhang
et al., 2003). Blockade of TRAIL, CD95L, or tumor necro-
sis factor-a (TNF-a) did not markedly reduce death in Th2
cells. Hence, TCR-ICD in Th2 cells occurs through an
unidentified mechanism. Here we showed that Th2 cells,
but not Th1 cells, treated with a GrB inhibitor or derived
from GrB-deficient mice were resistant to TCR-ICD.
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238Figure 1. Kinetics of TCR-ICD in Th1 and Th2 Cells
Helper T cell subsets differentiated from BALB/c splenocytes were cultured on anti-CD3-coated plastic to initiate TCR-ICD as described in Ex-
perimental Procedures. Apoptosis was determined by flow cytometric analysis of cells costained with annexin V-FITC and propidium iodide (PI).
Cells positive for Annexin V and negative for PI are early apoptotic, as shown 8 hr postactivation (A). Anti-CD3-activated Th1 cells or Th2 cells
were analyzed at the indicated time points (B). Viability was determined by analysis of cell membrane permeability to PI and plotted against FSC
at 8 hr (C); values for multiple time points are shown (D). Values are means6SE from four experiments. TCR-ICD at each time point is significantly
different as determined by repeated measures ANOVA, p < 0.01.We found that CD4+ T cells from OVA-immunized mice
produced more IL-4, IL-5, and IL-10 when treated with
a GrB inhibitor. Similarly, GrB-deficient mice produced
more of these Th2 cytokines. Most importantly, GrB-
deficient mice were found to be highly susceptible to
allergen-induced asthma. We conclude that granzyme B
activation is required for the TCR-ICD of Th2 cells, and
thus likely plays a role in modulating the Th2 response.
Results
TCR-ICD Is More Rapid in Th1 Cells than in Th2 Cells
Stimulation of T cell hybridomas (Mercep et al., 1988; Shi
et al., 1989) or restimulation of previously activated pri-
mary T cells (Lenardo, 1991) usually leads to apoptosis.
Previous studies revealed that Th2 cells are more resis-
tant than Th1 cells to TCR-induced cell death (TCR-ICD)
(Zhang et al., 1997), but the differences in their kinetics
of apoptosis have not been formally determined. We
generated Th1 and Th2 cells from murine splenocytes
ex vivo and then restimulated them with immobilized
CD3 antibody to initiate TCR-ICD. Cell death was moni-
tored by flow cytometry to detect Annexin V binding (a
measure of early apoptosis) and changes in light-scatter
characteristics, as well as subsequent membrane per-
meability to propidium iodide (PI) (Figures 1A and 1C).
Th1 cells died more quickly and more extensively than
Th2 cells, as detected by either technique (Figures 1Band 1D). Furthermore, DNA fragmentation as indicated
by emergence of a hypodiploid PI-stained DNA peak oc-
curred more quickly in Th1 cells at all time points from
8 to 18 hr (data not shown). These results demonstrate
that both Th1 and Th2 cells undergo apoptosis after re-
stimulation; Th1 cell death, however, takes place more
quickly and more profoundly. The difference in kinetics
of TCR-ICD in Th1 and Th2 cells suggest a likely diver-
gence in their mechanisms of apoptosis.
TCR-ICD in Th2 Cells Does Not Require TNF Family
Members or Major Caspases
To determine whether ligands of the TNF superfamily
are involved in TCR-ICD of helper T cell subsets, we
added specific blocking agents to anti-CD3-restimu-
lated Th1 or Th2 cells and observed the effect on apo-
ptosis by DNA content analysis (Figure 2A). As ex-
pected, the TCR-ICD of Th1 cells was inhibited by
antibody against CD95L (MFL3) and by recombinant hu-
man TR6 (DcR3), which binds to both CD95L and LIGHT
(Migone et al., 2002). None of these agents, however, af-
fected TCR-ICD in Th2 cells, corroborating our earlier re-
port that apoptosis in Th1 cells relies mostly on CD95L
(Zhang et al., 2003). In contrast, soluble TRAIL receptor,
DR5, had no effect on either helper T cell subset. Thus,
TRAIL is not involved in the TCR-ICD of Th2 cells, al-
though it is expressed by these cells. As demonstrated
earlier, TRAIL as expressed by Th2 cells can kill Th1
Granzyme B and Th2 Apoptosis
239Figure 2. Differential Caspase Activation Profiles and Responses to Apoptosis Inhibitors in Th1 and Th2 Cells
Differentiated Th1 cells or Th2 cells were plated on immobilized anti-CD3 to initiate TCR-ICD in the presence of the indicated inhibitors used at
optimal concentration: TR6 (100 ng/mL), DR5 (10 mg/mL), osteoprotegerin (OPG, 250 ng/mL), CD95L antibody (MFL3, 100 ng/mL), or z-VAD (5–
250 mM). The percentage of cells in late apoptosis at 16 hr was revealed by hypodiploid DNA content in permeabilized cells stained with PI and
analyzed by flow cytometry. Net increases in percentage of apoptotic cells above spontaneous levels were calculated and are presented as
means 6 SE of four experiments. Differences between Th1 and Th2 cells were found to be significant by Student’s t test (A and B): activation
of caspase-8 was measured by flow cytometric detection of a caspase 8-specific fluorogenic synthetic substrate. The difference between
Th1 and Th2 is significant by repeated measures ANOVA, p < 0.01 (C). General caspase activation was measured with a pan-caspase substrate,
zVAD-FITC. Dead cells were excluded by PI permeability (D).cells, but not Th2 cells themselves (Zhang et al., 2003).
Addition of osteoprotegerin (OPG), which blocks RANKL
and TRAIL, also affected neither cell type (Figure 2A).
Involvement of TNF-awas similarly ruled out by antibody
neutralization. Therefore, although CD95L is critical for
the TCR-ICD of Th1 cells, none of the known TNF family
members is implicated in the TCR-ICD in Th2 cells, sug-
gesting that Th2 cells employ a distinct mechanism of
TCR-ICD compared to Th1 cells.
To further dissect the mechanisms of TCR-ICD, cas-
pase utilization in each helper T cell subset was ana-
lyzed by adding z-VAD, which blocks the activity of sev-
eral major caspases, especially caspases 1, 3, 8, and 9
(Komoriya et al., 2000). We found that z-VAD signifi-
cantly inhibited TCR-ICD in Th1 cells, but not Th2 cells,
at all concentrations tested (Figure 2B); z-VAD at 100 mM
or less was shown to be nontoxic during the 24 hr culture
as determined by cell-viability analysis and prolifera-
tion (data not shown). Because TCR-ICD in Th1 cells is
inhibited by z-VAD as well as by antibody against
CD95L, Th1 apoptosis must depend on the CD95-trig-
gered caspase pathway. Therefore, we examined acti-
vation kinetics of initiator caspase 8 by using relatively
specific fluorogenic substrates. Caspase 8 was acti-
vated markedly in Th1 cells, but weakly in Th2 cells
(Figure 2C). General caspase activation, assayed viathe relatively broad substrate, z-VAD-FITC, was also
dramatically higher in Th1 cells compared to Th2 cells
(Figure 2D). Therefore, although TCR-ICD of Th2 cells
exhibits the typical characteristics of TCR-ICD, it is not
mediated by known ligands of the TNF superfamily,
nor does it involve the major caspases. Because we
have reported that the TCR-ICD of Th2 cells does not
occur through fratricide (Zhang et al., 2003), it is likely to
be an internal process.
Role of Granzyme B in TCR-ICD of Th2 Cells
Granzymes can act upon the cells containing them, as
has been demonstrated in CD16-stimulated NK cells
(Ida et al., 2003) and glucocorticoid-treated B leukemia
cells (Yamada et al., 2003). Thus, we hypothesize that
granzymes may be involved in Th2 cell death. One of
these, granzyme B (GrB), is a serine protease that was
identified in the granules of cytotoxic T cells and NK
cells. To determine its possible role in Th2 cell TCR-
ICD, we added a GrB inhibitor, z-AAD-CMK, to cultures
of restimulated Th2 cells and examined its effect on ap-
optosis. GrB inhibitor prevented apoptosis in a dose-
dependent manner, whereas Th1 cell cultures were
unaffected (Figure 3A). A control peptide, z-FA-CMK,
had no effect on either cell type. Furthermore, blockade
of cathepsin C (dipeptidyl peptidase I, DPP-I), whose
Immunity
240Figure 3. GrB Inhibition or GrB Deficiency Abolishes Caspase Activity and DNA Fragmentation in Th2 Cells
Cultures of differentiated Th1 cells or Th2 cells from BALB/c mice were restimulated with plastic bound anti-CD3 in the presence of graded con-
centrations of GrB inhibitor (z-AAD-CMK) or a negative control (z-FA-CMK), or a DPP-I inhibitor (Gly-Phe-CHN2) to prevent activation of cathep-
sin C, and the percentage of apoptotic cells was determined by hypodiploid DNA content after 16 hr (A and B). Differentiated Th1 cells or Th2 cells
from Gzmb2/2/DPGK-neo or 129/SvJ were restimulated with anti-CD3 for 8 hr, and caspase 3 activation was measured by flow cytometric de-
tection of caspase-specific fluorogenic synthetic substrates (C). The percentage of apoptotic cells after 16 hr with and without restimulation is
shown by hypodiploid DNA content (D).activity is required for GrB activation (Meade et al.,
2006), also reduced TCR-ICD in Th2 cells specifically
(Figure 3B). All apoptotic characteristics, including An-
nexin V binding, caspase activation, and loss of genomic
DNA, were inhibited in Th2 cells by inhibition of GrB or
cathepsin C (data not shown); Th1 cells were unaffected.
To further verify the role of granzyme B in TCR-ICD of
Th2 cells, we employed mice deficient in granzyme B
(Revell et al., 2005). Th1 and Th2 cells from Gzmb2/2/
DPGK-neo mice and control 129/SvJ mice were acti-
vated with plate bound anti-CD3 and assessed for the
activation of caspases 3 and 8, and for TCR-ICD by
the appearance of a hypodiploid DNA peak (Figure 3D).
TCR-induced activation of caspase 3 (Figure 3C) and
caspase 8 (not shown) was observed in Th1 cells derived
from both control and GzmB2/2 mice. In contrast, Th2
cells derived from control mice had a moderate increase
in caspase 3 activation, while Th2 cells from GzmB2/2
mice showed no activation of caspase 3 (Figure 3C) or
other caspases, as detected by z-VAD-FITC (not
shown), indicating that what little caspase activation
does occur in Th2 cells is GrB dependent. Further, while
GzmB2/2 Th1 cells underwent normal TCR-ICD, Th2
cells derived from these mice were resistant to TCR-
ICD. As a control, Th2 cells similarly derived from wild-
type 129/SvJ mice underwent normal TCR-ICD that
was sensitive to DPP-I inhibitor (data not shown). Similar
results were obtained with GzmB2/2/+GK-neo mice,
which are deficient in granzymes C and F, as well asGrB (data not shown). Taken together, these results
demonstrate that the TCR-ICD of Th2 cells, but not
Th1 cells, is likely to depend on a GrB-mediated apopto-
sis pathway.
Differential Activity of GrB in Helper T Cell Subsets
Since we have shown that GrB inhibitors block TCR-ICD
in Th2 cells, but not Th1 cells, and Th2 cells derived from
GrB knockout mice are resistant to TCR-ICD, we exam-
ined GrB mRNA levels in Th1 and Th2 cells by Northern
blotting analysis and real-time PCR. Surprisingly, both
resting and activated Th1 cells, as well as activated
Th2 cells, were found to express high levels of GrB
mRNA. GrB mRNA was low in resting Th2 cells, but in-
creased significantly upon activation (Figure 4A). This
result was verified by real-time PCR analysis. First,
equal loading was determined by b-actin mRNA detec-
tion, and then the Th1 or Th2 character of our cell prep-
arations was confirmed by examining IFN-g and IL-4, re-
spectively (Figure 4B). Finally, real-time PCR analysis of
GrB mRNA was found in the same unexpected pattern
as seen in our Northern blot (Figure 4B). Thus, the GrB
mRNA expression pattern detected by both Northern
analysis and real-time PCR does not explain why GrB in-
hibitors block TCR-ICD in Th2 cells but not Th1 cells.
GrB is sequestered in the cytoplasmic granules of
cells that harbor this enzyme (Catalfamo and Henkart,
2003; Raja et al., 2003). Since we have shown that Th2
cells are not killed by cell-cell contact (Zhang et al.,
Granzyme B and Th2 Apoptosis
241Figure 4. Differential Expression of Serine Protease Inhibitors and GrB in Th1 Cells and Th2 Cells
Differentiated helper T cell subsets were restimulated with immobilized anti-CD3 for 6 hr, and total mRNA was prepared and analyzed for GrB,
SPI-6, SPI-2A, IFN-g, FasL, GAPDH, and b-Actin by Northern blotting analysis (A) and real-time PCR (B). GAPDH or b-actin served as endogenous
controls to normalize total RNA. The presence of mRNA for IFN-g and IL-4, respectively, was used to verify that Th1 and Th2 cells were properly
differentiated. The results are representative of three experiments.2003), it is likely that the effect of GrB on TCR-ICD is ex-
erted by intracellular release of the enzyme. Therefore,
we examined GrB degranulation in both Th1 cells and
Th2 cells before and after stimulation with CD3 antibody.
Because all granules possess LAMP-1 (lysosome-asso-
ciated membrane protein-1, CD107a) (Alter et al., 2004;
Peters et al., 1991), we used confocal microscopy to ex-
amine for the colocalization of GrB (anti-GrB-PE) and
LAMP-1 (anti-LAMP-1-FITC). As shown in Figure 5A,
GrB and LAMP-1 colocalize in resting Th1 cells andTh2 cells, shown in yellow in the overlaid images.
Upon activation, GrB and LAMP-1 remain colocalized
in Th1 cells even after the cells have died, as indicated
by fragmented nuclei. In activated Th2 cells, separation
of red and green fluorescence was seen. Furthermore,
GrB appears in the nuclei of activated Th2 cells (Fig-
ure 5A), demonstrating that GrB is being released from
the granules. Therefore, activation of Th2 cells results
in the intracellular degranulation of GrB. Interestingly,
adding a cathepsin C (DPP-I) inhibitor (Gly-Phe-CHN2)Figure 5. Differential GrB Degranulation in Th1 Cells and Th2 Cells
Th1 and Th2 cells were reactivated with anti-CD3 for 12 hr, permeabilized, and stained with anti-LAMP-1-FITC and anti-GrB-PE, then washed
and counterstained with Hoechst 33342 nuclear stain. The cells were then visualized by laser-scanning confocal microscopy. Images are as
follows: top left, Hoechst 33342 nuclear stain; top right, LAMP-1; bottom left, GrB-FITC; bottom right, their overlay. Degranulation of GrB is
visualized as the diffusion of the normal punctate distribution of red fluorescence into the rest of the cell including the nucleus, which can
be observed to a great extent only in activated Th2 cells. In the overlaid images, GrB degranulation is shown by the disassociation of GrB
(red) from LAMP-1 (green) (A). Addition of a DPP-I inhibitor to Th2 cell cultures prevented TCR-induced GrB degranulation (B). Th2 cells derived
from Gzmb2/2 and control mice were activated and stained to show the specificity of GrB staining. There is no GrB staining in cells derived from
Gzmb2/2 mice (C).
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242Figure 6. Effect of Granzyme B on Th1-Th2 Cytokine Production
Gzmb2/2 and 129/SvJ mice were immunized with 10 mg OVA in ALUM, and cultures of CD4+ splenocytes were assayed for IFN-g, IL-4, IL-5, and
IL-13; IFN-g was not detectable. Differences in cytokine levels between control and Gzmb2/2 mice were analyzed (A). BALB/c mice were immu-
nized by tail base injection of 10 mg OVA in incomplete Freund’s adjuvant. After 7 days, splenocytes were stimulated (7.53 106 cells/mL) with OVA
(100 mg/mL) in the presence or absence of z-VAD or GrB inhibitor (each at 100 mM). Supernatant medium was collected after 48 hr and assayed for
IFN-g and IL-4. (B) Th1 cells or Th2 cells differentiated from BALB/c mouse splenocytes were reactivated with anti-CD3 in the presence of the
indicated inhibitors at optimal concentrations as in Figure 2. Supernatants were collected after 48 hr and analyzed for the indicated cytokines via
a multiplexed assay (C and D). Values represent means 6 SE of three experiments. Comparisons by Student’s t test are indicated.blocked TCR-induced degranulation in Th2 cells
(Figure 5B). The specificity of the GrB antibody was as-
certained by comparing staining of Th2 cells derived
from 129/SvJ and GzmB2/2 mice. Upon activation with
anti-CD3, the red staining (anti-GrB-PE) was observed
only in cells derived from 129/SvJ mice, not those from
GzmB2/2 mice (Figure 5C). Similarly, GrB staining was
not observed in activated Th1 or resting Th1 and Th2
cells from GzmB2/2 mice (data not shown). These data
provide direct evidence for TCR-induced degranulation
of GrB uniquely in Th2 cells.
Recent studies have revealed that cells possessing
granzymes generally also have inhibitors or mecha-
nisms to inactivate them in order to prevent autodes-
truction (Bots et al., 2005). Hence, we compared the ex-
pression of certain serine protease inhibitors in Th1 cells
and Th2 cells. Serine protease inhibitor (SPI)-6, which
specifically inhibits granzyme B activity, was found to in-
crease after TCR activation only in Th1 cells (Figure 4A).
Interestingly, SPI-2A, which inhibits both caspases 3
and 9, was found to increase only in activated Th2 cells.
Thus, while Th1 cells express some GrB, it remains con-
fined to granules; in case of minor leakage, GrB activ-
ity would be blocked by SPI-6. Real-time PCR analysis
also demonstrated this divergent pattern of SPI-6 and
SPI-2A expression among activated Th1 and Th2 cells
(data not shown). Thus, the preferential expression of
SPI-6 by Th1 cells may provide another defense mecha-
nism against GrB-induced death in these cells. How-
ever, we currently have no direct evidence to support
such a role for SPI-6.Modulation of GrB Activity Favors the Development
of Th2-Type Immune Responses
Our results show that the TCR-ICD of Th1 cells is medi-
ated by CD95L, while GrB mediates Th2 cell death. Our
previous studies have shown that CD4+ T cells derived
from lpr mice produce more Th1 cytokines under unbi-
ased conditions, indicating that Th1 cell expansion is fa-
vored by the absence of CD95L (Zhang et al., 2003). To
examine the role of GrB in influencing the type of im-
mune response in vivo, GzmB2/2 mice and control
129/SvJ mice were immunized with OVA in alum (see Ex-
perimental Procedures). CD4+ cells were isolated 5 days
post-boost and restimulated with OVA in vitro for 48 hr,
and then supernatants were assayed for cytokine levels.
We found that IL-4, IL-5, and IL-13 were significantly
higher in Gzmb2/2 mice (Figure 6A), while IFN-g was
undetectable. Thus, GrB deficiency favors the develop-
ment of Th2-type immunity in response to specific
antigen challenge, suggesting that GrB may play an im-
portant role in modulating Th2-type immune responses
in vivo.
We then asked whether Th subset-specific manipula-
tion of TCR-ICD could bias an immune response to anti-
gen. To test this possibility, we used specific inhibitors
of TCR-ICD during the generation of OVA-specific
helper T cell subsets and examined the resultant im-
mune response. Splenocytes isolated from normal
BALB/c mice 7 days after immunization with OVA in in-
complete Freund’s adjuvant were stimulated with OVA
in vitro under unbiased growth conditions. To these cul-
tures, we added either the caspase inhibitor, z-VAD,
Granzyme B and Th2 Apoptosis
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itor, which protects Th2 cells. Cells cultured without in-
hibitors served as controls. These expanded cultures
were subsequently restimulated with OVA and cytokine
production measured in the supernatant by multiplexed
cytokine assay (BioPlex System, Bio-Rad). We found
a striking divergence in the Th1 and Th2 signature cyto-
kines: while both types of cytokines were produced by
control cultures, inhibition of caspase activity by z-
VAD resulted in significantly increased IFN-g production
and less IL-4; conversely, inhibition of GrB caused a dra-
matic drop in IFN-g and significantly increased IL-4
(Figure 6B). A similar boost in IL-4 levels resulted when
DPP-I inhibitor was used to block cathepsin C activity.
Thus, inhibition of caspase activity resulted in a Th1-
skewed response, while GrB inhibition caused an exag-
gerated Th2-type response. This result not only con-
firms the selective protective effect of these inhibitors
on Th1 and Th2 cells, but also shows that we were
able to manipulate this antigen-specific secondary im-
mune response toward the Th1 or Th2 type by adding
specific protease inhibitors that favor the survival of
one type of helper T cell over another.
To verify the influence of TCR-ICD on the expansion of
helper T cell subsets, anti-CD3-stimulated differenti-
ated Th1 and Th2 cell cultures were rescued from
TCR-ICD, and changes in cytokine expression were ex-
amined. Rescue with FasL antibody caused IFN-g levels
to double in Th1 cell cultures (Figure 6C); the same oc-
curred with the addition of z-VAD (not shown). Con-
versely, inhibiting the activation of GrB by blockade of
cathepsin C (DPP-I) activation resulted in significant
increases in IL-4, IL-5, and IL-10 (Figure 6C). These re-
sults clearly demonstrate that specifically blocking the
death of Th1 or Th2 cells after TCR activation results in
prolonged cytokine production, providing further sup-
port for the notion that TCR-ICD can regulate the type
of immune response.
Gzmb2/2 Mice Develop More Severe
Allergen-Induced Asthma
To further evaluate the possible role of GrB in the gener-
ation of Th2 responses in a pathological setting in vivo,
we employed the mouse model of OVA-induced allergic
lung inflammation. It is well established that the devel-
opment of asthmatic airway inflammation (AAI) in this
model is solely dependent on the Th2-type immune
response. Therefore, we performed AAI experiments
with Gzmb2/2 mice and wild-type controls. Mice were
sensitized with i.p. injections of OVA (100 mg) plus alumi-
num hydroxide (Alum, 1 mg) as adjuvant on days 0 and 7.
On days 14–17, mice were challenged daily by intranasal
administration of OVA (50 ml of 0.5 mg/mL in sterile PBS)
or PBS alone. 24 hr after the last challenge, mice were
euthanized and the bronchio-alveolar lavage (BAL) fluid
was obtained by intratracheal infusion of PBS. Cells in
the BAL fluid were analyzed after H&E staining and leu-
kocyte differentials were enumerated. Airway inflamma-
tion is characterized by infiltration of leukocytes into the
areas surrounding the airways and some of the alveolar
space and by eosinophilia in the BAL fluid. Inflammatory
mediators in cell-free BAL fluid were determined by mul-
tiplexed assay for IL-4, IL-5, and IFN-g. Histological
changes in the lung are shown in Figure 7A. The severityof leukocyte infiltration was also quantified by two inde-
pendent observers in a double-blind fashion according
to the method established by Herrick (Herrick et al.,
2000); scores are presented in Figure 7B. Wild-type
mice show significant inflammatory cell infiltration after
OVA sensitization and challenge. Such infiltration is
more dramatic in Gzmb2/2 mice. Increased lung inflam-
mation was also manifest in the cellularity of the BAL, as
indicated by the fact that total cell numbers and eosino-
phil counts were significantly higher in Gzmb2/2 mice
than in wild-type controls (Figure 7C). The level of IL-4
and IL-5 in the BAL fluid of Gzmb2/2 mice was several
fold higher than in wild-type mice (w30 pg/mL in the
asthmatic BAL of wild-type mice; Figure 7D; Takeda
et al., 2005). IFN-g was undetectable in the BAL of either
group. Therefore, deficiency in GrB leads to a more po-
tent Th2-type immune response in vivo, even in a patho-
logical setting.
Discussion
Naive CD4+ T cells differentiate into Th1 or Th2 cells de-
pending on the cytokine environment and display differ-
ent immune functions and cytokine profiles upon stimu-
lation (Mosmann and Sad, 1996; Murphy, 1998).
Although much is known about the transcription factors
that regulate the production of several cytokines by Th1
and Th2 cells, the exact mechanisms controlling the es-
tablishment and persistence of a Th1- or Th2-type im-
mune response are not well defined. We have previously
shown that CD95L and TRAIL are induced after restimu-
lation of Th1 and Th2 cells, respectively, and that both
CD95L and TRAIL are able to kill Th1 cells (Zhang
et al., 2003). In the current study, we show that the
TCR-ICD of Th1 cells depends on the CD95-CD95L in-
teraction, while apoptosis of Th2 cells requires GrB ac-
tivation. Significantly, we were able to manipulate the
immune response in vivo toward a Th1 or a Th2 bias in
an asthma model by specifically rescuing one or the
other helper T cell subset from TCR-ICD, an intervention
that may have significant implications for treating dis-
eases perpetuated by a dysfunctional Th1-Th2 balance.
Our conclusion that GrB is important in the TCR-ICD
of Th2 cells is supported by several lines of evidence.
First, inhibitors of GrB or DPP-I prevented TCR-ICD
only in Th2 cells, not in Th1 cells. Second, Th2 cells de-
rived from Gzmb2/2mice were resistant to TCR-ICD. Fi-
nally, our confocal microscopy detection of the colocal-
ization of GrB and LAMP-1 provides direct evidence of
TCR-induced degranulation of GrB in Th2 cells. In
TCR-restimulated Th1 cells, in contrast, GrB still colo-
calized with LAMP-1 even after nuclear fragmentation
became apparent. Therefore, GrB degranulation is criti-
cal for the TCR-ICD of Th2 cells.
In experiments with anti-CD3-induced cell death, Th2
cells were not protected by CD95L antibody or the cas-
pase inhibitor, z-VAD, as were Th1 cells, suggesting dif-
ferent pathways of TCR-ICD in Th1 and Th2 cells. This
implies the possibility of altering the Th1/Th2 balance
in an immune response by manipulation of the different
pathways of TCR-ICD in Th1 and Th2 cells. The best
evidence is that in the absence of exogenous cytokines,
inhibition of apoptosis by anti-CD95L and soluble DR5
leads to an increase in IFN-g-producing cells (Zhang
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244Figure 7. Granzyme B-Deficient Mice Exhibit More Severe Allergen-Induced Asthma
GzmB2/2/DPGK-neo mice or 129/SvJ controls were sensitized by two i.p. injections of OVA plus ALUM on days 0 and 7. On days 14 to 17, mice
were challenged daily by intranasal injection of OVA (0.5 mg/mL in 50 ml sterile PBS) or PBS alone. Mice were euthanized on day 18, and bronchio-
alveolar lavage (BAL) fluid was obtained by intratracheal infusion of PBS. Lung tissue was fixed for histological sections and stained with H&E.
Arrows indicate infiltrated leukocytes (A). Microscopic examination was performed by two individuals and relative inflammatory index scored in
double-blinded fashion (B). Cells in BAL fluid were analyzed for total numbers of leukocytes and eosinophils per lung (C). Levels of IL-4 and IL-5 in
the BAL fluid were measured by multiplexed ELISA (D).et al., 2003). Our studies revealed that z-VAD has no ef-
fect on TCR-ICD and IL-4 production in differentiated
Th2 cells. This is also shown by Sehra et al. (2005) that
z-VAD has no effect on IL-4 production by committed
Th2 cells. However, the increase in TCR-induced IL-4
production by naive T cells (Sehra et al., 2005) could
be due to a different role of caspases at different stages
of T cell differentiation. Our conclusion of the role of
TCR-ICD in the Th1/Th2 balance is also supported by
our finding that Gzmb2/2 mice exhibit a dramatic in-
crease in Th2-type immune response and are highly sus-
ceptible to allergen-induced asthma. Therefore, GrB
participates in the regulation of Th2 responses.
By investigating the mechanism of CD95-mediated
apoptosis, we found that CD95L antibody, TR6, and
z-VAD were each able to block death in Th1 cells, while
Th2 cells were little affected. We conclude that Th1
cell death is triggered by the CD95-CD95L interaction
and mediated via caspase 8, which initiates the activa-
tion cascade of caspases 3 and 9, finally leading to cell
death. The TCR-ICD of Th2 cells, which occurs ata slower rate than for Th1 cells, was unrelated to the
TNF-family proteins, since neither anti-CD95L, TR6,
DR5, OPG, nor anti-TNF affected Th2 cell TCR-ICD. In
addition, our previous studies have shown that reacti-
vated Th2 cells can kill Th1 cells but not themselves,
while Th1 cells cannot kill Th2 cells. Instead, Th2 cells
undergo apoptosis by death receptor-independent
mechanisms (Zhang et al., 2003). Since apoptotic Th2
cells exhibit the typical early and late signs of TCR-
ICD, their apoptosis machinery must be intact—though
less vigorously activated—leading to lower levels of
caspase activation than in Th1 cells. The resistance of
Th2 cells to TCR-ICD may be attributable to the pres-
ence of FLIP (FLICE-like Inhibitory Protein), a caspase 8
homolog that inhibits caspase 8 activation. In fact, we
have reported much higher amount of FLIP protein in
Th2 cells compared to Th1 cells (Zhang et al., 2003), and
FLIP has been reported to downregulate caspase activa-
tion mediated by other receptors. Furthermore, we have
shown that the intracellular caspase inhibitor, SPI-2A,
is highly expressed after TCR-induced activation of
Granzyme B and Th2 Apoptosis
245Th2 cells, but not Th1 cells. Therefore, besides the lack
of FasL expression, it is likely the increased expression
of FLIP and SPI-2A that confers upon Th2 cells their
resistance to TCR-ICD.
Although some reports have shown that the TCR-ICD
of both Th1 and Th2 cells depends on the CD95-CD95L
interaction (Watanabe et al., 1997), recent reports are in-
creasingly showing strong evidence that Th1 and Th2
cells use different mechanisms to execute TCR-ICD
(Ramsdell et al., 1994; Varadhachary et al., 1997; Yates
et al., 2000; Zhang et al., 1997, 2003). The role of the
CD95-CD95L interaction in TCR-ICD has been reported
to be more important in Th1 cells than in Th2 cells
(Ramsdell et al., 1994; Zhang et al., 2001, 2003). Addi-
tional evidence from other groups suggests that the
presence of CD95/Fas-associated phosphatase (FAP)
potently unlinks CD95L signaling in Th2 cells (Varad-
hachary et al., 1997; Zhang et al., 1997). Surprisingly,
very little has been reported about the mechanism of
TCR-ICD in Th2 cells. The data presented here regarding
the critical role of GrB in the Th2 cell death suggest
a novel mechanism regulating the balance between
Th1 and Th2 cells.
We also report that activated Th1 cells express the
GrB inhibitor, SPI-6, while Th2 cells instead express
high levels of intracellular SPI-2A, an endogenous inhib-
itor of caspases 3 and 9. This reciprocal expression of
SPI-6 and SPI-2A shows that Th2 cells have no protec-
tion against GrB-mediated death but are protected
from the activity of several caspases; the opposite is
true for Th1 cells. Thus, it is not surprising that Th2 cell
death is characterized by low caspase activity and is
largely unaffected by caspase inhibitors, while Th1
death involves marked increases in caspase activity
and is unaffected by granzyme B inhibitors. Therefore,
the absence of SPI-6 in Th2 cells renders them suscep-
tible to death by TCR-activated granzymes.
The conversion of pro-granzyme B to active granzyme
B is mediated by cathepsin C. We have shown that exog-
enous inhibition of cathepsin C protects Th2 cells from
TCR-ICD. The role of GrB was confirmed in vivo by dem-
onstrating that Gzmb2/2 mice have a Th2-skewed im-
mune response. We also showed that the immune re-
sponse in OVA can be biased toward the Th1 or a Th2
type by rescue of the corresponding helper T cell with
specific inhibitors of apoptosis. Moreover, in the patho-
logical setting of OVA-induced asthma, a Th2-driven dis-
ease, significantly greater disease severity occurred in
Gzmb2/2 mice compared to normal mice. Therefore,
GrB plays a critical role in regulating Th2 response.
This seems discordant with the recent report suggesting
a critical role of NKT cells in asthma (Meyer et al., 2006).
We recently reexamined the role of CD4+ T cells via ge-
netically modified mice and showed that CD4+ T cells
are required for OVA-induced asthmatic airway inflam-
mation in several strains of mice tested (data not shown).
We have shown that GrB is the pivotal mediator of Th2
cell apoptosis. GrB can independently activate multiple
caspases, including caspases 1, 2, 3, 6, 7, 9, and 10 (Lie-
berman, 2003), and some caspase substrates, including
PARP and NuMA (Beresford et al., 1999). GrB has also
been shown to activate t-BID and cleave ICAD indepen-
dent of caspases (Barry et al., 2000; Thomas et al., 2001).
While it is uncertain whether the GrB-mediated Th2 cellapoptosis depends on the caspases or acts directly on
cellular substrates, we have shown that GrB activity is
elevated in Th2 cells and that inhibition of GrB rescues
Th2 cells from apoptosis, implicating its central role in
Th2 cell death. Further investigation of the mechanisms
by which GrB regulates TCR-ICD in Th2 cells will allow
us to better understand the mechanisms that modulate
Th2 response in normal and disease states.
Experimental Procedures
Reagents and Mice
Antibodies against murine CD95L (MFL3), CD95 (JO2), and FITC-
conjugated AnnexinV were from BD Biosciences/Pharmingen (San
Diego, CA). Antibodies against IFN-g, IL-4, IL-12, and GrB (16G6)
were purchased from eBiosciences (San Diego, CA). TNF-a, TRAIL,
IFN-g, and anti-TNF-a were from R&D Systems (Minneapolis, MN).
DR5 was a kind gift of Dr. Youhai Chen, University of Pennsylvania.
Caspases 1, 2, 3, 6, 8, and 9 were assayed by kits from Intergen, Inc.
(Purchase, NY). The GrB inhibitor, z-AAD-CMK, and its control,
z-FA-CMK, were from Calbiochem (San Diego, CA). Caspase inhib-
itor z-VAD was from Enzyme Systems (Livermore, CA). TR6 recombi-
nant protein was made by Human Genome Sciences (Rockville, MD).
The DPP-I inhibitor, Gly-Phe-CHN2 (MP Biochemicals, Aurora, OH),
was used to inhibit cathepsin C activity.
Female BALB/c mice at 5–8 weeks old were obtained from
National Cancer Institute (Frederick, MD), and Gzmb2/2 mice
(GzmB2/2/DPGK-neo) and wild-type controls (129/SvJ) (Revell
et al., 2005) were generously provided by Dr. Timothy Ley, Washing-
ton University Medical School. Mice were maintained in the Robert
Wood Johnson Medical School Vivarium. Animals were matched
for age and gender in each experiment. All animal experiments
were approved by the institutional Animal Care and Use Committee.
Differentiation of Helper T Cell Subsets
CD4+ T cells were purified from splenocytyes by negative selection
by means of immunoaffinity columns (mouse CD4+ T cell subset iso-
lation kit, R&D Systems) and differentiated under Th1- or Th2-gener-
ating conditions. CD4+ lymphocytes at 106/mL were activated with
anti-CD3 (1 mg/mL) bound to plastic and soluble anti-CD28 (2 mg/
mL). IL-12 (10 ng/mL) and anti-IL-4 (10 mg/mL) were included in
Th1 cultures, while IL-4 (5 ng/mL), anti-IL-12, and anti-IFN-g (each
at 10 mg/mL) were supplied for Th2 cultures. After 24 hr, IL-2 was
added to all cultures. Cells were divided at a 1:4 ratio after 3 days
and allowed to rest under the above cytokine conditions in the
absence of anti-CD3 and anti-CD28 for another 2 days. These cells
(1 3 106/mL) were then restimulated with plate bound anti-CD3
(1 mg/mL) to initiate TCR-ICD. All cell cultures were maintained
in RPMI 1640 medium supplemented with 2 mM L-glutamine,
50 mM 2-mercaptoethanol, 10% heat-inactivated FBS, and 10 mM
Gentamycin.
Northern Blot Analysis
Total RNA was isolated from differentiated helper T cell subsets via
affinity columns (Qiagen, Chatsworth, CA), according to the manu-
facturer’s protocol. RNA samples were fractionated on 1% aga-
rose/2.2 M formaldehyde denaturing gel and transferred onto a Ny-
tran membrane (Schleicher & Schuell, Inc., Keene, NH). DNA probes
were labeled with 32P-dCTP by random priming (Roche, Indianapo-
lis, IN) according to manufacturer’s instructions. Prehybridization
and hybridization were carried out at 42C in a solution containing
5 3 SSC (10 3 SSC is 1.5 M NaCl, 0.15 M sodium citrate), 2.5 mM
EDTA, 0.1% SDS, 53 Denhardt’s solution, 2 mM sodium pyrophos-
phate, 50 mM sodium phosphate, and 50% formamide. Membranes
were washed with 0.23 SSC, 0.1% SDS at 56C for 1 hr, and hybrid-
ization signals were detected by autoradiography.
Real-Time PCR
Total RNA was isolated with an RNeasy Mini Kit (Qiagen). Genomic
DNA was removed with RNase-free DNase prior to cDNA synthesis.
First-strand cDNA synthesis was performed for each RNA sample
with Sensiscript RT Kit (Qiagen). Reverse-transcribed cDNA was de-
termined by real-time PCR with SYBR Green Master Mix (Applied
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246Biosystems, Foster City, CA). The primers were: GrB: 50-ACTCTTG
ACGCTGGGACCTA, 50-AGTGGGGCTTGACTTCATGT; b-actin: 50-
GTGGGCCGCCCTAGGCACCA, 50-CTCTTTGATGTCACGCACGATT
TC; FasL: 50-TGGGTAGACAGCAGTGCCAC, 50-GCCCACAAGATG
GACAGGG; IFN-g: 50-TCAAGTGGCATAGATGTGGAAGAA, 50-TG
GCTCTGCAGGATTTTCATG; IL-4: 50-ACAGGAGAAGGGACGCCAT,
50-GAAGCCCTACAGACGAGCTCA. b-Actin gene was used as an en-
dogenous control to normalize for the amount of total RNA in each
sample. All values are expressed as relative fold increase or de-
crease compared to a control.
Confocal Microscopy
For subcellular localization of LAMP-1 (CD107a) and GrB, the cells
were fixed and permeabilized with a kit from BD Biosciences and
were then stained with FITC-labeled LAMP-1 and PE-labeled anti-
GrB (eBiosciences) for 20 min, counterstained with Hoechst 33342
nuclear stain, then washed and mounted on slides. The cells were
then visualized with a Zeiss LSM510 META laser scanning confocal
microscope with a 633 water immersion objective (NA 1.2). Sepa-
rate filter sets for FITC (488 nm excitation, a 505–550 nm band
pass emission), PE (543 nm excitation, 560 nm long pass emission),
and DAPI (351 nm excitation, 385–470 nm emission) were used for
image acquisition.
Blocking of Apoptosis
Differentiated helper T cells (106 cells/mL) were analyzed for apopto-
sis after activation in the presence or absence of the following
reagents: z-VAD (5–250 mM), z-AAD-CMK (a GrB inhibitor, 5–250
mM), anti-CD95L (MFL3, 50–1000 ng/mL), osteoprotegerin (OPG,
50–1000 ng/mL, R&D), DR5 (5–20 mg /mL), DMSO (0.1%–5%), TR6
(50–1000 ng/mL), or the DPP-I inhibitor, Gly-Phe-CHN2 (5–250
mM), each added 15–20 min prior to stimulation. Apoptosis was an-
alyzed by Annexin V binding and propidium iodide (PI) permeability.
PBS-washed cells were resuspended in 5 ml cold binding buffer con-
taining FITC-conjugated AnnexinV. The cell suspension was diluted
to 250 ml in a staining buffer (PBS with 2% FCS and 0.1% sodium
azide) with PI (25 mg/mL) and analyzed by flow cytometry. Viable
cells are defined as those negative for both PI and Annexin V, while
early apoptotic cells are Annexin V+PI2. Double-positive cells are
late apoptotic or necrotic. Only early apoptotic cells are included
in the data analysis. To determine total DNA content, cells were
resuspended in DNA staining buffer consisting of 0.5% saponin,
50 mg/mL PI, and 0.1 mg/mL RNase A in PBS and analyzed by flow
cytometry for the percentage of cells in the hypodiploid region.
Caspase Measurement
Activated caspases were detected with fluorogenic caspase sub-
strates (Intergen, Purchase, NY) according to the manufacturer’s
protocol. In brief, cells (1 3 106/mL) were stimulated with anti-
CD3, and 5 ml of the diluted caspase substrate was added. The cells
were then incubated at 37C for 1 hr, washed and resuspended in
PBS with 5 mg/mL PI, and analyzed by flow cytometry. The increase
in caspase+ PI2 population of the stimulated cells compared to un-
stimulated cells was calculated and plotted for each of the cas-
pases.
Immunization and Cytokine Measurement
BALB/c mice were immunized by tail-base injection of 10 mg OVA
(Grade V; Sigma) in 50 ml saline mixed with 50 ml of incomplete
Freund’s adjuvant. After 7 days, spleens were harvested, and
CD4+ cells were purified and stimulated (7.5 3 106 cells/mL) with
OVA (100 mg/mL) in the presence or absence of z-VAD or GrB inhib-
itor (each at 100 mM). Supernatant was collected at 48 hr and as-
sayed for IFN-g and IL-4 by ELISA. Gzmb2/2 or 129/SvJ wild-type
mice were immunized i.p. with 10 mg OVA mixed with 2 mg ALUM
in 200 ml PBS on days 0 and 7, and cell cultures were similarly pre-
pared and analyzed.
Induction of Allergic Airway Inflammation
8-week-old female Gzmb2/2 and wild-type mice (H2b) were sensi-
tized by i.p. injections of 100 mg of OVA plus 1 mg ALUM in 0.2 ml
PBS on days 0 and 7. On days 14–17, mice were challenged daily in-
tranasally with OVA (0.5 mg/mL in 50 ml PBS) or PBS alone. Mice
were euthanized 24 hr later, and BAL fluid was obtained by intratra-cheal infusion of 2 ml PBS, as described (Das et al., 2001). Cells in the
BAL fluid were analyzed on slides after H&E staining. Leukocyte dif-
ferentials were acquired on a CELL-DYN 3700 Hematology Analyzer.
Inflammatory mediators were determined in cell-free BAL fluid by
multiplexed cytokine assay for IL-4, IL-5, and IFN-g (BioPlex, Bio-
Rad, Hercules, CA).
Statistical Analysis
Differences in treatment groups were assessed by paired two-tail
Student’s t test or by analysis of variance (ANOVA) for repeated
measures, as indicated. The significance levels are indicated as fol-
lows: *p < 0.05; **p < 0.01; ***p < 0.001.
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